The new iPad is quietly online: Can it help Apple enter the 3 trillion medical market?

On March 21, the maintenance of Apple's official online store ended, and a wave of new products was announced as we expected. Without a press conference, you naturally can't see new heavy products. But even so, we can still figure out a lot of information.

Aside from the special red version of the iPhone 7/7 Plus, which is of public interest, the iPhone SE, which is upgraded to 32GB and 128GB of storage, is also very interesting. There is also an iPad with only 128GB option, but the price is lowered. Mini 4. Of course, the most interesting thing is to replace the new iPad, the new iPad, after the iPad Air 2.

The iPad came out entirely for the cheap market because we saw too much sacrifice and compromise in it. Compared with the replaced iPad Air 2, the iPad has increased thickness and weight by about 20%, but the performance of the processor has improved. In order to control costs, the features of fully laminated display, anti-reflective coating, and DCI-P3 wide color gamut have been eliminated. Although Apple did not launch such a pro-people product before, the technical compromise is too crisp, but it still makes people react.

What you don't know is that buying new Apple products can be more than just ordinary consumers - large hospitals and medical systems that use iOS may purchase these tablets in bulk. For Apple, the $3 trillion medical market offers great potential for iPad sales growth.

Shaun Miller, a doctor at the Westside Sinai Medical Center in Los Angeles, said: "We now have hundreds of iPads for patients." He is using a medical app that complies with the iPhone standard to connect with other providers. “The ward is still growing, and the hospital may have thousands of iPads at the same time.”

新版iPad将要上市:能否帮苹果打入3万亿医疗市场?

The Siddes Sinai Medical Center has hundreds of iPads for patients to use.

Medical "mobilization", a difficult potential market

In the Internet age, the iPad is no longer a revolutionary product, but it is a huge advancement for the medical community, and patients can get their digital medical information with their fingers. In 2009, the HITECH bill cost the federal government $35 billion to launch digital medical data; but even today, eight years later, many doctors and patients are still using USB flash drives or CD-ROMs to store and access medical data. For them, Turning data to the mobile side is a very new thing.

The main reason why medical “mobilization” is more difficult than other industries is that many organizations still use internal pre-deployed enterprise software. The CEO of Tonic Health, which developed the gamification medical information form, said that medical applications are the last area where there is significant room for improvement in design and user experience.

Anti-Viral


The virus is composed of a nucleic acid molecule (DNA or RNA) with a protein consisting of non-cell morphology of the campal life of the living body. The general symptoms of viral infection are fever, headache, cough and other symptoms of systemic poisoning and viral host and invasion of tissues and organs leading to inflammatory symptoms caused by local symptoms (diarrhea, rash, liver function damage, etc.). Different symptoms of the different virus, some viruses can also damage the myocardium, causing viral myocarditis. There are two types of viral infections, mostly recessive infections (subclinical infections), and a few are dominant infections. Dominant infection can be divided into acute infection and persistent infection. There are many ways of antiviral infection, such as direct inhibition or killing of viruses, interference with virus adsorption, prevent viruses from penetrating cells, inhibit viral biosynthesis, inhibit viral release or enhance host antivirus capabilities. At present, there are several major types of antiviral drugs: Anti-Respiratory virus infection drugs, anti-immune virus drugs, anti-hepatitis virus drugs, anti-herpes virus drugs.



Anti-Viral Intermediate,Pharmacogenetics Testing,Anti-HIV Pharmaceutical Intermediates,Anti-HCV Pharmaceutical Intermediates,Antiviral Drugs for Flu

Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com